CRISPLD2 Antibody
-
货号:CSB-PA884430LA01HU
-
规格:¥440
-
促销:
-
图片:
-
其他:
产品详情
-
产品名称:Rabbit anti-Homo sapiens (Human) CRISPLD2 Polyclonal antibody
-
Uniprot No.:Q9H0B8
-
基因名:CRISPLD2
-
别名:CRISP-11 antibody; CRISP11 antibody; Crispld2 antibody; CRLD2_HUMAN antibody; Cysteine-rich secretory protein 11 antibody; Cysteine-rich secretory protein LCCL domain-containing 2 antibody; DKFZP434B044 antibody; LCCL domain-containing cysteine-rich secretory protein 2 antibody; LCRISP2 antibody; MGC74865 antibody
-
宿主:Rabbit
-
反应种属:Human
-
免疫原:Recombinant Human Cysteine-rich secretory protein LCCL domain-containing 2 protein (40-305AA)
-
免疫原种属:Homo sapiens (Human)
-
标记方式:Non-conjugated
本页面中的产品,CRISPLD2 Antibody (CSB-PA884430LA01HU),的标记方式是Non-conjugated。对于CRISPLD2 Antibody,我们还提供其他标记。见下表:
-
克隆类型:Polyclonal
-
抗体亚型:IgG
-
纯化方式:>95%, Protein G purified
-
浓度:It differs from different batches. Please contact us to confirm it.
-
保存缓冲液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
产品提供形式:Liquid
-
应用范围:ELISA, WB
-
推荐稀释比:
Application Recommended Dilution WB 1:500-1:1000 -
Protocols:
-
储存条件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
货期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
相关产品
靶点详情
-
功能:Promotes matrix assembly.
-
基因功能参考文献:
- Our results suggest that CRISPLD2 rs4783099 may represent a risk factor for NSCPO (non-syndromic oral clefts). PMID: 27328068
- Data suggest that suppression of CRISPLD2 increases the risk of lung inflammation in early life and adulthood. PMID: 27597766
- Our data suggest that CRISPLD2 may have a unique anti-HMGB1 effect via miRNA155 and play an important role in immune balance. PMID: 26624800
- CRISPLD2 is a target of progesterone receptor and its expression is decreased in women with endometriosis. PMID: 24955763
- Results demonstrate genetic polymorphism of CRISPLD2 gene is associated with an increased risk of non-syndromic cleft lip with or without cleft palate. PMID: 25496823
- findings define a role for LGL1 in fibroblast expansion and migration, epithelial cell migration, and mesenchymal-epithelial signaling, key processes in fetal lung development. PMID: 25480331
- results support the hypothesis that variants in the CRISPLD2 gene may be involved in the etiology of NS CL(P). PMID: 20815724
- Both LCCL-domains of human CRISPLD2 have high affinity for lipid A. PMID: 24090571
- There is a decreased expression of CRISPLD2 in septic shock and it is association with procalcitonin in sepsis. PMID: 23799041
- CRISPLD2 gene contributes to the etiology of NSCLP in the Northwestern Chinese population. SNP rs1546124 is significantly related to NSCLP, associated with both CL/P and CPO groups, and SNP rs4783099 is significantly associated with CPO. PMID: 21800413
- the present investigation did not support the hypothesis of the involvement of CRISPLD2 in nonsyndromic cleft lip and palate PMID: 21244519
- three SNPs in northern Chinese population found an association between these polymorphisms and NSCLP in both single-marker and haplotype analyses. data further strengthen the conclusion that altered CRISPLD2 is associated with NSCLP susceptibility. PMID: 20662919
- CRISPLD2 is expressed in the mandible, palate and nasopharynx regions during craniofacial development at E13.5-E17.5, respectively. Altogether, these data suggest that genetic variation in CRISPLD2 has a role in the etiology of NSCLP. PMID: 17616516
- present work introduces mammal CRISPLD2 as a major serum protein that acts as a natural LPS antagonist and promises to be of considerable preventative value against endotoxic shock. PMID: 19864597
显示更多
收起更多
-
亚细胞定位:Secreted.
-
蛋白家族:CRISP family
-
数据库链接:
HGNC: 25248
OMIM: 612434
KEGG: hsa:83716
STRING: 9606.ENSP00000262424
UniGene: Hs.513779
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IF, FC
Species Reactivity: Human, Mouse, Rat
-
-
-
-
-
-